Hi SpeedStone.
The value of this company is much higher than it is now.
Until the begining of the sales of ruconest really start, Pharming will stay around these levels.
In other hand, i think this will start to change when Pharm announce the 2010 results.
They have receveid a lot of cash and was able to clean there balance sheet.
Ruconest work started 10 years ago, but the result will in 2011 and 2011 to the shareholders.
Stay with us SpeedStone. There are more people interested in pharm. Go to the Boursorama forum of pharm and you will see that.
If you see the CNBC channel the quote of pharming sometimes is starting to apear.thats a good sign.
Stay focus and value of this company will be 350-500millions, what means in the share price around 0,7-1€.
The value of this company is much higher than it is now.
Until the begining of the sales of ruconest really start, Pharming will stay around these levels.
In other hand, i think this will start to change when Pharm announce the 2010 results.
They have receveid a lot of cash and was able to clean there balance sheet.
Ruconest work started 10 years ago, but the result will in 2011 and 2011 to the shareholders.
Stay with us SpeedStone. There are more people interested in pharm. Go to the Boursorama forum of pharm and you will see that.
If you see the CNBC channel the quote of pharming sometimes is starting to apear.thats a good sign.
Stay focus and value of this company will be 350-500millions, what means in the share price around 0,7-1€.
Recent PHARM News
- Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older • GlobeNewswire Inc. • 03/27/2026 06:00:00 AM
- Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older • GlobeNewswire Inc. • 03/24/2026 06:00:00 AM
- Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow • GlobeNewswire Inc. • 03/12/2026 06:00:00 AM
- Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day • GlobeNewswire Inc. • 02/03/2026 06:00:00 AM
- Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS • GlobeNewswire Inc. • 02/01/2026 08:17:00 PM
- DAX, CAC, FTSE100, European equities drift lower amid U.S.–Venezuela tensions and data watch • UK Market News • 01/08/2026 02:17:15 PM
- Pharming Group reports preliminary 2025 revenues and announces Investor Day • GlobeNewswire Inc. • 01/08/2026 06:00:00 AM
- Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow • GlobeNewswire Inc. • 11/06/2025 06:00:00 AM
- Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio • GlobeNewswire Inc. • 10/20/2025 06:00:33 AM
- Pharming Group provides update on previously announced G&A expense reduction plan • GlobeNewswire Inc. • 10/06/2025 03:35:57 PM
- Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years • GlobeNewswire Inc. • 10/01/2025 05:00:25 AM
- Pharming Group promoted to the Euronext AMX® index • GlobeNewswire Inc. • 09/10/2025 05:00:00 AM
- Pharming Group appoints Kenneth Lynard as Chief Financial Officer • GlobeNewswire Inc. • 09/02/2025 05:00:00 AM
- Pharming Group reports second quarter and first half 2025 financial results and provides business update • GlobeNewswire Inc. • 07/31/2025 05:00:00 AM
- Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis • GlobeNewswire Inc. • 06/24/2025 05:00:00 AM
- Pharming Group reports first quarter 2025 financial results and provides business update • GlobeNewswire Inc. • 05/08/2025 05:00:00 AM
